Esmya (ulipristal acetate) 5mg - Important Safety Information from Gedeon Richter UK Ltd as approved by the HPRA

Notice type: 3rd Party Publications

Date: 03/02/2021




Problem Or Issue:

Important Safety Information from Gedeon Richter UK Ltd regarding Esmya (ulipristal acetate) 5mg: Indications for uterine fibroids restricted due to concerns of severe liver injury


 

Important Safety Information - Esmya (ulipristal acetate) 5mg




« Back